hydrochlorothiazide has been researched along with candesartan in 74 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 32 (43.24) | 29.6817 |
| 2010's | 39 (52.70) | 24.3611 |
| 2020's | 3 (4.05) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Barragan, J; Bernhardi, DC; Bunt, T; Cabrera, WJ; Dumortier, T; Grossman, E; Jacovides, A; Jelakovic, B; Manolis, AJ; Matadamas, N; Mejia, AD; Mendiola, A; Smith, RD; Watanabe, LA; Woo, KS; Zhu, JR | 1 |
| Welch, WJ; Wilcox, CS | 1 |
| Abe, I; Kagiyama, S; Lin, Y; Matsumura, K; Tsuchihashi, T | 1 |
| Weisser, B | 1 |
| Elmfeldt, D; Hansson, L; Hofman, A; Lithell, H; Olofsson, B; Skoog, I; Trenkwalder, P; Zanchetti, A | 1 |
| Preobrazhenskiĭ, DV; Sidorenko, BA; Stetsenko, TM; Tarykina, EV; Tsurko, VV | 1 |
| Bombelli, M; Dell'Oro, R; Facchini, A; Grassi, G; Mancia, G; Scopelliti, F; Seravalle, G; Trevano, FQ | 1 |
| Arnolda, LF; Molloy, D; Upton, J; Wing, LM | 1 |
| Degl'Innocenti, A; Elmfeldt, D; Hofman, A; Lithell, H; Olofsson, B; Skoog, I; Trenkwalder, P; Wiklund, I; Zanchetti, A | 1 |
| Arakawa, K | 1 |
| Williams, B | 1 |
| Elmfeldt, D; Farsang, C; Hofman, A; Lithell, H; Olofsson, B; Papademetriou, V; Skoog, I; Trenkwalder, P; Zanchetti, A | 1 |
| Mancia, G; Omboni, S | 1 |
| Ijzerman, RG; Schalkwijk, CG; Schram, MT; Spoelstra-de Man, A; Stehouwer, CD; Twisk, JW; van Dijk, RA; van Ittersum, FJ | 1 |
| Ishimitsu, T; Matsuoka, H; Minami, J | 1 |
| Brouwer, CB; Ijzerman, RG; Kamp, O; Schram, MT; Spoelstra-de Man, AM; Stehouwer, CD; Twisk, JW; van Dijk, RA; van Ittersum, FJ | 1 |
| Mengden, T; Tousset, E; Uen, S; Vetter, H | 1 |
| Abe, C; Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Takahashi, T | 1 |
| Corradi, L; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Handrock, R; Hilsmann, U; Klebs, S; Neumann, G; Schweizer, J | 1 |
| Fujita, T; Gohchi, K; Shimosawa, T; Yatomi, Y | 1 |
| Audia, P; Dubrow, A; Feinfeld, DA; Winchester, JF | 1 |
| Bramlage, P; Funken, C; Odoj, P; Schönrock, E; Wolf, WP | 1 |
| Kato, N; Liang, YQ; Ochiai, Y; Serizawa, M | 1 |
| Ahlström, H; Carlberg, B; Eriksson, JW; Hägg, A; Jansson, PA; Johansson, L; Kurland, L; Lind, L; Lönn, L; Ojbrandt, K; Ström, C; Svensson, MK | 1 |
| Bramlage, P; Odoj, P; Schönrock, E | 1 |
| Bönner, G | 1 |
| Elmfeldt, D; Karlson, BW; Olofsson, B; Zetterstrand, S | 1 |
| Borthen, C; Eggebøe, T; Ellingsen, CL; Oglaend, B; Schjøtt, J | 1 |
| Eguchi, K; Hoshide, S; Kabutoya, T; Kario, K; Shimada, K | 1 |
| Hosoya, T; Kuriyama, S; Otsuka, Y; Sugano, N; Ueda, H; Yamada, T; Yoshizawa, T | 1 |
| Jin, D; Miyazaki, M; Sakonjo, H; Shimosato, T; Takai, S | 1 |
| Benduhn, H; Klebs, S; Schweizer, J; Ulmer, HJ | 1 |
| Eriksson, JW; Jansson, PA; Johansson, A; Johansson, L; Karlsson, C; Lind, L; Palming, J; Renström, F | 1 |
| Nirnberger, G; Pittrow, LA; Slany, J | 1 |
| Ishii, H; Kobayashi, S; Suzuki, O | 1 |
| Bramlage, P; Hübner, R; Mengden, T | 1 |
| Chen, YL; Chui, H; Hajjar, I; Hart, M; Lipsitz, L; Mack, W; Milberg, W | 1 |
| Fujiwara, W; Ishii, J; Izawa, H; Kinoshita, K; Morimoto, S; Mukaide, D; Nomura, M; Ozaki, Y; Ukai, G; Yokoi, H | 1 |
| Bailey, KR; Boerwinkle, E; Chai, HS; Chapman, AB; Schwartz, GL; Turner, ST | 1 |
| Bharathi, DV; Chatki, PK; Hotha, KK; Satyanarayana, V; Venkateswarlu, V | 1 |
| Cho, EJ; Choi, KY; Ihm, SH; Jang, SW; Kim, DB; Kim, JH; Kwon, BJ; Youn, HJ | 1 |
| Akiyama, H; Hasegawa, Y | 1 |
| Bailey, K; Boerwinkle, E; Chapman, AB; Schwartz, GL; Turner, ST | 1 |
| Farinde, A | 1 |
| Boomsma, F; Danser, AH; Schilders, JE; van den Meiracker, AH; Wu, H | 1 |
| Abdel Monem Hegazy, M; Fayez, YM | 1 |
| Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Donner, KM; Frau, F; Glorioso, N; Glorioso, V; Gong, Y; Gums, JG; Hiltunen, TP; Johnson, JA; Kontula, KK; Ripatti, S; Saarela, J; Salvi, E; Sarin, AP; Turner, ST; Zaninello, R | 1 |
| Asayama, K; Hirose, T; Hosaka, M; Imai, Y; Inoue, R; Kikuya, M; Metoki, H; Obara, T; Ohkubo, T; Satoh, M | 1 |
| Arora, A; Jain, S; Khuller, GK; Malhotra, S; Shafiq, N; Sharma, S | 1 |
| Avezum, A; Bosch, J; Chazova, I; Dagenais, G; Dans, A; Diaz, R; Fodor, GJ; Held, C; Jansky, P; Keltai, K; Keltai, M; Kim, JH; Kunti, K; Leiter, L; Lewis, B; Liu, L; Lonn, E; Lopez-Jaramillo, P; Pais, P; Parkhomenko, A; Peters, RJ; Piegas, LS; Pogue, J; Reid, CM; Sliwa, K; Toff, WD; Varigos, J; Xavier, D; Yusoff, K; Yusuf, S; Zhu, J | 1 |
| Accini, JL; Avezum, A; Bosch, J; Chazova, I; Dagenais, G; Dans, A; Diaz, R; Held, C; Jansky, P; Jung, H; Keltai, K; Keltai, M; Khunti, K; Leiter, LA; Lewis, BS; Liu, L; Lonn, E; López-Jaramillo, P; McKelvie, R; Pais, P; Parkhomenko, A; Peters, RJ; Piegas, LS; Pogue, J; Reid, CM; Sliwa, K; Toff, WD; Varigos, J; Xavier, D; Yusoff, K; Yusuf, S; Zhu, J | 1 |
| Avezum, A; Bosch, J; Chazova, I; Dagenais, G; Dans, A; Diaz, R; Held, C; Jansky, P; Jung, H; Keltai, K; Keltai, M; Khunti, K; Leiter, LA; Lewis, BS; Liu, L; Lonn, EM; López-Jaramillo, P; McKelvie, R; Molina, DI; Pais, P; Parkhomenko, A; Peters, RJ; Piegas, LS; Pogue, J; Reid, CM; Sliwa, K; Toff, WD; Varigos, J; Wilkinson, J; Xavier, D; Yusoff, K; Yusuf, S; Zhu, J | 1 |
| Ridker, PM | 1 |
| Eaton Md, CB | 2 |
| Alonso-Galicia, M; Corona, A; Felix, JP; Garcia, ML; Gill, C; Hampton, C; Kaczorowski, GJ; Kohler, M; Liu, J; Metzger, JM; Ormes, J; Owens, K; Pai, LY; Pasternak, A; Price, O; Priest, BT; Rasa, C; Roy, S; Shah, K; Sullivan, KA; Tang, H; Thomas-Fowlkes, B; Tong, V; Xiao, J; Zhou, X | 1 |
| Danilov, SM; Dull, RO; Schwartz, DE; Tovsky, SI | 1 |
| Bohm, M; Bosch, J; Dans, A; Joseph, P; Keltai, M; Khunti, K; Kim, JH; Lonn, E; Lopez, P; Piegas, L; Reid, C; Swaminathan, B; Toff, W; Yusuf, S; Zhu, J | 1 |
| Avezum, A; Bogaty, PM; Bosch, J; Dagenais, GR; Dehghan, M; Held, C; Jansky, P; Jung, H; Keltai, M; Leiter, LA; Lonn, E; Lopez-Jaramillo, P; Toff, WD; Yusuf, S | 1 |
| Ekman, I; Lind, L; Lytsy, P; Marttala, K; Nowrouzi, S; Öhagen, P; Östlund, O; Sundström, J | 1 |
| Bosch, J; Dans, A; Jung, H; Kamath, D; Liu, L; Lonn, E; Pais, P; Yusuf, S; Zhu, J | 1 |
| Bosch, J; Gafni, A; Jung, H; Lamy, A; Lonn, E; Swaminathan, B; Tong, W; Yusuf, S | 1 |
| Avezum, A; Bosch, J; Dagenais, G; Dans, A; Diaz, R; Hart, R; Held, C; Keltai, M; Khunti, K; Lee, SF; Leiter, LA; Lewis, BS; Lonn, EM; O'Donnell, M; Pogue, JM; Reid, C; Sharma, M; Sliwa, K; Swaminathan, B; Toff, WD; Yusuf, S | 1 |
| Bachmann, HS; Besser, M; Severing, AL; Stuermer, EK; Terberger, N | 1 |
| Bhandari, RK; Bhatia, A; Kaur, N; Malhotra, S; Pandey, AK; Rather, IIG; Shafiq, N; Sharma, S | 1 |
| Hagström, E; Held, C; Lind, L; Lytsy, P; Marttala, K; Neal, B; Nowrouzi, S; Östlund, O; Sundström, J | 1 |
5 review(s) available for hydrochlorothiazide and candesartan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Angiotensin I receptor antagonist losartan. Part II. Effects in arterial hypertension and diabetic nephropathy].
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diastole; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Losartan; Meta-Analysis as Topic; Placebos; Prognosis; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Systole; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2003 |
[Development of combined drugs (ARB and diuretics)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Diuretics; Drug Combinations; Drug Design; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Kidney Tubules, Proximal; Losartan; Olmesartan Medoxomil; Practice Guidelines as Topic; Renin-Angiotensin System; Sodium; Telmisartan; Tetrazoles | 2004 |
Protection against stroke and dementia: an update on the latest clinical trial evidence.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Cognition; Dementia; Hydrochlorothiazide; Ramipril; Stroke; Tetrazoles; Verapamil | 2004 |
[Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diuretics; Drug Combinations; Family Practice; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Practice Guidelines as Topic; Risk Factors; Sodium Chloride Symporter Inhibitors; Tetrazoles; Time Factors; Treatment Outcome | 2008 |
39 trial(s) available for hydrochlorothiazide and candesartan
| Article | Year |
|---|---|
Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Tetrazoles | 2000 |
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Cognition; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Follow-Up Studies; Helsinki Declaration; Humans; Hydrochlorothiazide; Hypertension; Male; Prognosis; Prospective Studies; Risk Reduction Behavior; Severity of Illness Index; Survival Analysis; Tetrazoles; Time Factors; Treatment Outcome | 2003 |
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Female; Humans; Hydrochlorothiazide; Hypertension; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Obesity; Sympathetic Nervous System; Tetrazoles | 2003 |
Candesartan and hydrochlorothiazide in isolated systolic hypertension.
Topics: Aged; Aged, 80 and over; Australia; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Weight; Clinical Protocols; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Selection; Sample Size; Tetrazoles; Time Factors; Treatment Outcome | 2003 |
Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE).
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cognition; Double-Blind Method; Europe; Female; Follow-Up Studies; Health Status Indicators; Humans; Hydrochlorothiazide; Hypertension; Male; Prognosis; Quality of Life; Tetrazoles; Treatment Outcome; United States | 2004 |
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Europe; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Receptor, Angiotensin, Type 1; Risk Factors; Stroke; Systole; Tetrazoles; Time Factors; Treatment Outcome | 2004 |
Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure Determination; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Oscillometry; Tetrazoles; Time Factors | 2004 |
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized c
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hydrochlorothiazide; Hypertension; Inflammation; Lisinopril; Male; Middle Aged; Tetrazoles | 2005 |
Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Compliance; Diabetes Mellitus, Type 2; Diastole; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Middle Aged; Organ Size; Systole; Tetrazoles; Ventricular Function, Left | 2006 |
Management of patients with uncontrolled arterial hypertension--the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCTZ.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Drug Monitoring; Drug Therapy, Combination; Electronics, Medical; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Office Visits; Patient Compliance; Tetrazoles | 2006 |
Long-term efficacy of combination therapy with losartan and low-dose hydrochlorothiazide in patients with uncontrolled hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2007 |
Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nitrobenzenes; Piperazines; Prospective Studies; Proteinuria; Single-Blind Method; Tetrazoles | 2007 |
Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination.
Topics: Benzimidazoles; Biphenyl Compounds; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Tetrazoles; Valine; Valsartan | 2007 |
Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine.
Topics: Aged; Amlodipine; Antihypertensive Agents; Asian People; Benzimidazoles; Biphenyl Compounds; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Losartan; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome | 2007 |
[Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diuretics; Drug Combinations; Family Practice; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Practice Guidelines as Topic; Risk Factors; Sodium Chloride Symporter Inhibitors; Tetrazoles; Time Factors; Treatment Outcome | 2008 |
Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Composition; Cross-Over Studies; Diabetes Mellitus, Type 2; Diuretics; Fatty Liver; Female; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hydrochlorothiazide; Hyperinsulinism; Hypertension; Insulin Resistance; Intra-Abdominal Fat; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Tetrazoles | 2008 |
Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diuretics; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Young Adult | 2008 |
A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Clinical Laboratory Techniques; Clinical Protocols; Diastole; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patients; Placebos; Research; Systole; Tetrazoles | 2009 |
Efficacy and tolerability of aliskiren 300 mg/hydrochlorothiazide 25 mg (± amlodipine 5 mg) in hypertensive patients not controlled by candesartan 32 mg plus HCT 25 mg.
Topics: Adult; Aged; Algorithms; Amides; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Failure; Treatment Outcome | 2011 |
Hydrochlorothiazide compared to candesartan treatment increases adipose tissue gene expression and circulating levels of serum amyloid A in hypertensive patients.
Topics: Adipose Tissue; Amyloid; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Gene Expression; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles | 2011 |
Cardiovascular risk stratification and antihypertensive therapy according to guidelines in the outpatient setting.
Topics: Age Factors; Aged; Ambulatory Care; Antihypertensive Agents; Austria; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Risk Assessment; Sex Factors; Tetrazoles; Treatment Outcome | 2011 |
Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI CU Soon.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Prospective Studies; Tetrazoles | 2011 |
Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial.
Topics: Age Factors; Aged; Benzimidazoles; Biphenyl Compounds; Blood Pressure Determination; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Sex Factors; Tetrazoles; Treatment Outcome | 2012 |
Low dose of hydrochlorothiazide, in combination with angiotensin receptor blocker, reduces blood pressure effectively without adverse effect on glucose and lipid profiles.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Lipids; Male; Middle Aged; Tetrazoles; Time Factors; Treatment Outcome | 2013 |
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Black or African American; Blood Pressure; Case-Control Studies; Chi-Square Distribution; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 16; Diuretics; Drug Administration Schedule; Epithelial Sodium Channels; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Tetrazoles; White People | 2012 |
Comparison of the efficacy between hydrochlorothiazide and chlorthalidone on central aortic pressure when added on to candesartan in treatment-naïve patients of hypertension.
Topics: Adult; Antihypertensive Agents; Arterial Pressure; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chlorthalidone; Cross-Over Studies; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome; Vascular Stiffness | 2013 |
Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
Topics: Aged; Aldosterone; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Phenotype; Precision Medicine; Renin; Renin-Angiotensin System; Tetrazoles | 2014 |
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
Topics: Adult; Aldehyde Oxidoreductases; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Blood Pressure Monitoring, Ambulatory; Chloride Channels; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Essential Hypertension; Finland; Genome-Wide Association Study; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Membrane Proteins; Meta-Analysis as Topic; Microfilament Proteins; Middle Aged; Mutation, Missense; Pharmacogenetics; Polymorphism, Single Nucleotide; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2015 |
Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome; Young Adult | 2015 |
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Global Health; Humans; Hydrochlorothiazide; Incidence; Male; Middle Aged; Population Surveillance; Primary Prevention; Risk Factors; Rosuvastatin Calcium; Tetrazoles; Treatment Outcome | 2016 |
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Medication Adherence; Middle Aged; Risk Factors; Rosuvastatin Calcium; Tetrazoles | 2016 |
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Hypotension; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; Tetrazoles | 2016 |
ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Enalapril; Genotype; Humans; Hydrochlorothiazide; Hypertension; Patient Selection; Peptidyl-Dipeptidase A; Pharmacogenetics; Pharmacogenomic Testing; Pharmacogenomic Variants; Phenotype; Precision Medicine; Predictive Value of Tests; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome | 2017 |
Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Libido; Male; Middle Aged; Penile Erection; Risk Factors; Rosuvastatin Calcium; Sexuality; Tetrazoles | 2018 |
Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Female; Healthy Lifestyle; Humans; Hydrochlorothiazide; Male; Middle Aged; Primary Prevention; Risk Factors; Rosuvastatin Calcium; Tetrazoles; Treatment Outcome | 2018 |
The Precision HYpertenSIon Care (PHYSIC) study: a double-blind, randomized, repeated cross-over study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Precision Medicine; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Tetrazoles | 2019 |
Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asia; Asian People; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Cholesterol, LDL; Double-Blind Method; Down-Regulation; Drug Combinations; Dyslipidemias; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Rosuvastatin Calcium; Sodium Chloride Symporter Inhibitors; Tetrazoles; Time Factors; Treatment Outcome | 2019 |
The cost implication of primary prevention in the HOPE 3 trial.
Topics: Antihypertensive Agents; Australia; Benzimidazoles; Biphenyl Compounds; Canada; Cardiovascular Diseases; Drug Combinations; Europe; Health Care Costs; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Primary Prevention; Rosuvastatin Calcium; Tetrazoles; United States | 2019 |
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Precision Medicine | 2023 |
31 other study(ies) available for hydrochlorothiazide and candesartan
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Drug Combinations; Feedback; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney; Kidney Glomerulus; Kidney Tubules; Nitric Oxide; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Reserpine; Signal Transduction; Tetrazoles; Transforming Growth Factors | 2001 |
The influence of chronic antihypertensive treatment on the central pressor response in SHR.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Brain; Enalapril; Epinephrine; Heart Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Injections, Intraventricular; Losartan; Male; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Saline Solution, Hypertonic; Tetrazoles | 2001 |
[Report of experiences. Walk in the woods by a retiree without leg edema].
Topics: Benzimidazoles; Biphenyl Compounds; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Jogging; Lymphedema; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2001 |
[AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diuretics; Double-Blind Method; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Losartan; Meta-Analysis as Topic; Placebos; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Stroke; Tetrazoles; Time Factors; Valine; Valsartan | 2003 |
[Beneficial effects of combination therapy with losartan and low-dose hydrochlorothiazide in the treatment of essential hypertension].
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Tetrazoles | 2005 |
Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction.
Topics: Acidosis, Lactic; Acute Disease; Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Celecoxib; Cyclooxygenase Inhibitors; Diuretics; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrochlorothiazide; Hypoglycemic Agents; Metformin; Middle Aged; Pancreatitis; Pharmaceutical Preparations; Polypharmacy; Pyrazoles; Renal Dialysis; Sodium Bicarbonate; Sulfonamides; Tetrazoles | 2008 |
Dynamic changes of the renin-angiotensin and associated systems in the rat after pharmacological and dietary interventions in vivo.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Dietary Fats; Diuretics; Enalapril; Gene Expression Regulation; Hydrochlorothiazide; Male; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Chloride, Dietary; Tetrazoles | 2008 |
Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care.
Topics: Abdominal Fat; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Cholesterol, HDL; Clinical Trials as Topic; Diuretics; Drug Interactions; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Risk Factors; Tetrazoles | 2008 |
Warnings against candesartan in pregnancy are not implemented in physicians' practice.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Female; Fetal Death; Humans; Hydrochlorothiazide; Hypertension; Oligohydramnios; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Cardiovascular; Tetrazoles | 2009 |
Is very low dose hydrochlorothiazide combined with candesartan effective in uncontrolled hypertensive patients?
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Circadian Rhythm; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sleep; Tetrazoles | 2010 |
Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hydrochlorothiazide; Hypertension; Peritoneal Dialysis; Tetrazoles | 2011 |
Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats.
Topics: Acetylcholine; Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Vessels; Diuretics; Drug Therapy, Combination; Gene Expression Regulation; Hydrochlorothiazide; Male; Malondialdehyde; NADPH Oxidases; Rats; Rats, Inbred SHR; Rats, Wistar; Stroke; Superoxide Dismutase; Tetrazoles; Vasodilation; Vasodilator Agents | 2011 |
Effects of an angiotensin 2 receptor blocker plus diuretic combination drug in chronic heart failure complicated by hypertension.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chronic Disease; Diuretics; Drug Combinations; Female; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Male; Prognosis; Renin-Angiotensin System; Tetrazoles | 2011 |
LC-MS/MS method for simultaneous estimation of candesartan and hydrochlorothiazide in human plasma and its use in clinical pharmacokinetics.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Humans; Hydrochlorothiazide; Liquid-Liquid Extraction; Statistics, Nonparametric; Tandem Mass Spectrometry; Tetrazoles | 2012 |
Migraine treated using a prophylactic combination of candesartan and hydrochlorothiazide (ECARD Combination Tablets LD).
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Combinations; Edema; Female; Humans; Hydrochlorothiazide; Leg; Middle Aged; Migraine Disorders; Tablets; Tetrazoles | 2013 |
The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertension.
Topics: Adult; Age Factors; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Black People; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Radioimmunoassay; Renin; Retrospective Studies; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome; White People | 2013 |
Drugs for treating hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drugs, Generic; Humans; Hydrochlorothiazide; Hypertension; Nifedipine; Prescription Drugs; Ramipril; Tetrazoles | 2013 |
Mean centering of ratio spectra and concentration augmented classical least squares in a comparative approach for quantitation of spectrally overlapped bands of antihypertensives in formulations.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Hydrochlorothiazide; Irbesartan; Least-Squares Analysis; Spectrophotometry; Tablets; Tetrazoles | 2015 |
Development of Sustained Release "NanoFDC (Fixed Dose Combination)" for Hypertension - An Experimental Study.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Drug Carriers; Drug Liberation; Half-Life; Hydrochlorothiazide; Hypertension; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tetrazoles | 2015 |
Is Statin Monotherapy the Perfect Polypill?
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Dyslipidemias; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multicenter Studies as Topic; Risk; Rosuvastatin Calcium; Tetrazoles | 2016 |
Combination candesartan-HCTZ did not reduce major CV events in patients at intermediate CV risk.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Tetrazoles | 2016 |
Adding candesartan-HCTZ to rosuvastatin increased adverse events but not benefits in patients at intermediate CV risk.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Humans; Hydrochlorothiazide; Hypertension; Rosuvastatin Calcium; Tetrazoles | 2016 |
The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II Phenotype.
Topics: Animals; Bartter Syndrome; Benzimidazoles; Benzofurans; Biphenyl Compounds; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; HEK293 Cells; Humans; Hydrochlorothiazide; Male; Phenotype; Piperazines; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Rats; Tetrazoles | 2016 |
Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cognition; Cognitive Dysfunction; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypolipidemic Agents; Male; Rosuvastatin Calcium; Tetrazoles | 2019 |
Side Effects of Frequently Used Antihypertensive Drugs on Wound Healing in vitro.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Cell Line; Cell Movement; Diuretics; Fibroblasts; Humans; Hydrochlorothiazide; Keratinocytes; Metoprolol; Ramipril; Tetrazoles; Wound Healing | 2019 |
Pharmacokinetic and pharmacodynamic evaluation of nano-fixed dose combination for hypertension.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Drug Combinations; Hydrochlorothiazide; Hypertension; Male; Nanoparticles; Rats; Rats, Wistar; Tetrazoles | 2020 |